tirzepatide phase 3 trial

tirzepatide phase 3 trial Efficacy and safety of in children and adolescents with type 2 diabetes (SURPASS-PEDS): a randomised, double-blind, placebo-controlled, CagriSema vs Tirzepatide: 23% Weight

Name: tirzepatide phase 3 trial Efficacy and safety of in children and adolescents with type 2 diabetes (SURPASS-PEDS): a randomised, double-blind, placebo-controlled, CagriSema vs Tirzepatide: 23% Weight
Brand: inmobiliariafranchi.com
SKU: 45344376933
Price: 27.78 USD
Availability: InStock
Rating: 4.2061 (23 reviews)

SKU: 45344376933

4.2

USD27.78 USD65.78

Pay in 4 interest-free payments of $6.95 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 15 - Aug 20

Description

Presented for research literature review only Nikolaeva A et al

In the OASIS 4 clinical trial, 7 percent of participants taking the oral Wegovy pill discontinued treatment due to side effects, compared with 6 percent in the placebo group